Coinbase has once again sent shockwaves through the crypto market by adding Bio Protocol (BIO) and Euler (EUL) to its asset roadmap. This move triggered immediate price surges—17% for BIO and 3.5% for EUL—before settling slightly lower. But what does this mean for investors? Let’s dive in.
Why Are BIO and EUL Tokens Gaining Attention?
Coinbase’s announcement on July 29, 2025, via an X post, has put BIO and EUL in the spotlight. Here’s why these tokens matter:
- BIO: Powers the decentralized science (DeSci) ecosystem BioDAOs, enabling tokenized biotech research.
- EUL: The governance token for Euler Finance, facilitating lending and borrowing on Ethereum.
The Coinbase Effect: Short-Term Surge or Long-Term Gain?
Historically, the “Coinbase effect” has led to short-term price rallies. However, outcomes vary:
| Token | Initial Surge | Long-Term Impact |
|---|---|---|
| BIO | 17% | Muted due to existing liquidity |
| EUL | 3.5% | Limited by competition |
What Are the Risks for Investors?
While Coinbase’s credibility often boosts listings, risks remain:
- Market saturation from existing exchanges like Binance and Kraken.
- Historical precedents of tokens crashing post-listing (e.g., NEWT dropped 44%).
- No guarantee of final listing—Coinbase’s roadmap is just an evaluation.
Should You Invest in BIO and EUL Tokens?
Analysts suggest caution. While Coinbase’s interest in DeFi and DeSci is clear, the tokens’ established presence on other exchanges may limit upside. Always conduct due diligence.
FAQs
1. What is the Coinbase effect?
The “Coinbase effect” refers to the short-term price surge often seen after a token is announced or listed on Coinbase.
2. Will BIO and EUL be listed on Coinbase?
Inclusion in the roadmap doesn’t guarantee listing. It only indicates Coinbase is evaluating the tokens.
3. Why did BIO surge more than EUL?
BIO’s niche in DeSci may have sparked higher speculative interest compared to EUL’s broader DeFi use case.
4. Are BIO and EUL good long-term investments?
It depends on market conditions, token supply, and investor sentiment. Research is key.
